| 73 |
Thyroid Lobectomy as an Initial Treatment Option on 1-4 cm Papillary Cancer1-4 cm 갑상선 유두상암의 초기 수술로 엽절제술의 적용
Jin-Seong Cho조진성
KMSID: 1148546 Int J Thyroidol. 2021;14(2):73-80. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.73 |
|
| 81 |
Optimal Surgical Extent of Therapeutic Lateral Neck Dissection in Well-Differentiated Thyroid Carcinoma Patients with Clinical Lateral Lymph Node Metastasis분화갑상선암 환자에서 치료적 측경부림프절 절제술의 적절한 범위
Ho-Ryun Won, Bon Seok Koo원호륜, 구본석
KMSID: 1148547 Int J Thyroidol. 2021;14(2):81-86. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.81 |
|
| 87 |
Completion Thyroidectomy잔존 갑상선절제술
Yongil Cheon, Sung-Chan Shin, Byung-Joo Lee천용일, 신성찬, 이병주
KMSID: 1148548 Int J Thyroidol. 2021;14(2):87-92. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.87 |
|
| 93 |
Tips for Preservation of Parathyroid Gland During Thyroid Surgery갑상선 수술에서 부갑상선을 보존하기 위한 수술 술기
Jung-Han Kim김정한
KMSID: 1148549 Int J Thyroidol. 2021;14(2):93-97. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.93 |
|
| 98 |
Current Status and Future Perspective of the Treatment for Radioiodine Refractory Differentiated Thyroid Cancer방사성요오드 불응성 분화갑상선암의 치료, 현재의 상황과 향후 전망
Young Kee Shong송영기
KMSID: 1148550 Int J Thyroidol. 2021;14(2):98-111. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.98 |
|
| 112 |
Neck Discomfort after Thyroidectomy갑상선절제술 후 경부불편감
Beomsoo Kim, Jae Hong Park김범수, 박재홍
KMSID: 1148538 Int J Thyroidol. 2021;14(2):112-116. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.112 |
|
| 117 |
Thyroid and Gut Microbiome갑상선과 장내 마이크로바이옴
Seul Ki Kwon, Namil Kim, Young Joo Park권슬기, 김남일, 박영주
KMSID: 1148541 Int J Thyroidol. 2021;14(2):117-126. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.117 |
|
| 127 |
Treatment Effect of Combining Lenvatinib and Vemurafenib for BRAF Mutated Anaplastic Thyroid CancerTreatment Effect of Combining Lenvatinib and Vemurafenib for BRAF Mutated Anaplastic Thyroid Cancer
Chae Moon Hong, Ji Min Oh, Prakash Gangadaran, Ramya Lakshmi Rajendran, Byeong-Cheol AhnChae Moon Hong, Ji Min Oh, Prakash Gangadaran, Ramya Lakshmi Rajendran, Byeong-Cheol Ahn
KMSID: 1148537 Int J Thyroidol. 2021;14(2):127-134. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.127 |
|
| 135 |
Null Association between BRAF V600E Mutation and Tumor Recurrence in Patients with Papillary Thyroid Microcarcinoma in South KoreaNull Association between BRAF V600E Mutation and Tumor Recurrence in Patients with Papillary Thyroid Microcarcinoma in South Korea
Ji Yoon Kim, Kyoung Jin Kim, Jae Hyun Bae, Joo Hyung Kim, Nam Hoon Kim, Hee Young Kim, Hoon Yub Kim, Seung-Kuk Baek, Sin Gon Kim, Kwang Yoon Jung, Kyeong Jin KimJi Yoon Kim, Kyoung Jin Kim, Jae Hyun Bae, Joo Hyung Kim, Nam Hoon Kim, Hee Young Kim, Hoon Yub Kim, Seung-Kuk Baek, Sin Gon Kim, Kwang Yoon Jung, Kyeong Jin Kim
KMSID: 1148539 Int J Thyroidol. 2021;14(2):135-142. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.135 |
|
| 143 |
Serum Carcinoembryonic Antigen as a Biomarker for Medullary Thyroid CancerSerum Carcinoembryonic Antigen as a Biomarker for Medullary Thyroid Cancer
Jinyoung Kim, Hyunju Park, Min Sun Choi, Jun Park, Hye Won Jang, Tae Hyuk Kim, Sun Wook Kim, Jae Hoon ChungJinyoung Kim, Hyunju Park, Min Sun Choi, Jun Park, Hye Won Jang, Tae Hyuk Kim, Sun Wook Kim, Jae Hoon Chung
KMSID: 1148540 Int J Thyroidol. 2021;14(2):143-151. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.143 |
|
| 152 |
Cooperative Subtype Switch of Thyroid Hormone Receptor and Nuclear Receptor Corepressor Related Epithelial–Mesenchymal Transition in Papillary Thyroid CancerCooperative Subtype Switch of Thyroid Hormone Receptor and Nuclear Receptor Corepressor Related Epithelial–Mesenchymal Transition in Papillary Thyroid Cancer
Seonhyang Jeong, Seul Gi Lee, Hyunji Kim, Gibbeum Lee, Sunmi Park, In-Kyu Kim, Jandee Lee, Young Suk JoSeonhyang Jeong, Seul Gi Lee, Hyunji Kim, Gibbeum Lee, Sunmi Park, In-Kyu Kim, Jandee Lee, Young Suk Jo
KMSID: 1148542 Int J Thyroidol. 2021;14(2):152-169. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.152 |
|
| 170 |
Persistent Hypokalemic Paralysis in a Patient with Graves’ Disease and Gitelman SyndromePersistent Hypokalemic Paralysis in a Patient with Graves’ Disease and Gitelman Syndrome
Jin Woo Jeong, Tae Yang YuJin Woo Jeong, Tae Yang Yu
KMSID: 1148543 Int J Thyroidol. 2021;14(2):170-174. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.170 |
|
| 175 |
A Newly Developed Pancreatic Adenocarcinoma in a Patient with Advanced Thyroid Cancer under Long-Term Sorafenib UseA Newly Developed Pancreatic Adenocarcinoma in a Patient with Advanced Thyroid Cancer under Long-Term Sorafenib Use
Min Ji Kim, Han-Sang Baek, Sung Hak Lee, Dong-Jun LimMin Ji Kim, Han-Sang Baek, Sung Hak Lee, Dong-Jun Lim
KMSID: 1148545 Int J Thyroidol. 2021;14(2):175-179. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.175 |
|
| 180 |
Subacute Thyroiditis Developed While Waiting for Papillary Thyroid Cancer Surgery: Pathologically Proven Two CasesSubacute Thyroiditis Developed While Waiting for Papillary Thyroid Cancer Surgery: Pathologically Proven Two Cases
Do-Hoon Kim, Chae Moon Hong, Man-Hoon Han, Jaetae LeeDo-Hoon Kim, Chae Moon Hong, Man-Hoon Han, Jaetae Lee
KMSID: 1148544 Int J Thyroidol. 2021;14(2):180-185. Published online 2021 November 30 DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.180 |
|
